One of the conditions that can make a Medline Brand bed overheat, according to an FDA early alert posted October 29, is an extension cord. Others on the list include fluid getting into the hand control and a pendant Medline didn’t make. Medline has reported two deaths and 16 serious injuries as of October 20, and it is leaving the bed business. Its October 24 instructions to customers who still have the beds begin with unplugging them. A homecare bed can meet every one of those three conditions in an ordinary bedroom, and when a design leaves them to the user, an instruction like that is the only control left.
What the alert says sets off the fire
Medline found that the bed’s electrical parts, from the pendant to the control box to the motors, can overheat and progress to smoke, sparks, melting or fire. The alert names the conditions: excessive load on the system, jammed components or motors, a damaged pendant or fluid getting into it, extension cords, and pendants or accessories that Medline didn’t make or approve. The entrapment hazard carries its own list: any bed accessory, a patient lying on the pendant, rails that are loose or wobbly.
Jammed motors and excessive load involve a part or a system under strain. The extension cord, the spill and the substitute pendant need only a house. A bed at home goes where the room has space, which may leave the outlet beyond the reach of its cord. A drink on the nightstand can end up on the hand control. A broken pendant can be replaced with one from another supplier. A facility can assign someone to check the equipment and approve what gets attached to it. At home, that job falls to whoever is there.
Where a risk file sends conditions like these
ISO 14971 asks a manufacturer to analyze reasonably foreseeable misuse alongside intended use, and it ranks the ways to control a risk: design the hazard out, add a protective measure, or give the user information for safety. Information comes last because it works only if someone reads the warning and remembers it at 2 a.m. Once a team files the extension cord under misuse, the cheapest remaining control is a sentence in the instructions for use.
Medline’s October 24 instructions rely on that kind of sentence and on nothing else. Unplug the bed, and plug it in only while repositioning the patient. Don’t use an extension cord, and have a second person help whenever possible. A long-term care facility can write those steps into a shift procedure. A family caring for someone at home has to remember them several times a day, and the second person may be at work.
The removal needed its own plan
Medline’s first notice, on October 14, recommended taking the beds out of use. Ten days later the company let them stay in service, with repair, replacement, or a full or partial refund available for beds bought in the last five years. Older beds get the instructions without that remedy. The alert doesn’t give a reason for the change. It does show a practical limit that any company retiring a home device runs into: a patient who sleeps in a powered bed still needs one the night it is taken away.
On my own hazard list, I’d go through every condition we labeled misuse and ask whether we labeled it that way because designing for it was inconvenient. An extension cord on a homecare bed would fail that test.
Dave’s take
I’d want the exit plan for a home device written while the product is still selling, because a removal notice has to work in the same bedroom the device does. Medline needed two notices, ten days apart, to settle what customers should do with beds already in use.
From Dave’s video library
Dave walks through Ford’s run of recalls and why it rehired about 350 veteran engineers after trying to hand their judgment to AI.
I’m here to help you scale.
Work With DavePrefer a smaller first step? Book a $500 one-hour working session →
Dave Saunders is the founder of Base Reality Group and a Fractional CPO for product companies. He was a founder and operator at Galen Robotics, where the surgical-robotics platform earned FDA De Novo authorization in 2023, and he managed a 35-patent portfolio licensed from Johns Hopkins. He wrote Founders Who Finish and publishes The Build. More about Dave →